Scipher Medicine rakes in $30 mln Series B
Scipher Medicine, a developer of a molecular technology platform, has raised $30 million in Series B financing.
Scipher Medicine, a developer of a molecular technology platform, has raised $30 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination